Results 151 to 160 of about 602,470 (307)

Retrospective review of on-call MRI scans for spinal trauma: discrepancy rates in registrar reports and lessons learned

open access: yesThe Royal College of Radiologists Open
Joyce Lim   +3 more
doaj   +1 more source

Evaluating hand hygiene compliance: a digital-based approach for assessing healthcare worker practices in the teaching hospitals in Malaysia. [PDF]

open access: yesAntimicrob Resist Infect Control
Lau MY   +6 more
europepmc   +1 more source

HOSPITAL TEACHING

open access: yesAcademic Medicine, 1927
openaire   +2 more sources

Over the edge: Empirical evidence for the cliff‐edge model of obstetric selection

open access: yesThe Anatomical Record, EarlyView.
Abstract The cliff‐edge model of obstetric selection maintains that larger neonates and smaller birth canals confer a positive selective advantage until labor becomes obstructed and vaginal delivery is no longer possible, eliciting an abrupt reduction in fitness.
Laura M. Watson   +6 more
wiley   +1 more source

Improving Neurosurgical Consenting: A Comparative Study of Paper-Based and Digital Methods

open access: yesBrain and Spine
Dr. Marwan Al-Munaer   +4 more
doaj   +1 more source

Eurocentric Bias in Dysmorphology and Medical Genetics Education

open access: yes
American Journal of Medical Genetics Part A, EarlyView.
D' Arcy B. Prendergast   +3 more
wiley   +1 more source

Risk Factors for Relapse in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis Among Patients With Relapse After Induction of Remission With Rituximab

open access: yesArthritis &Rheumatology, EarlyView.
Objective The objective of the study was to determine risk factors for relapse of antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV) after reinduction of remission with rituximab and discontinuation of maintenance therapy. Methods This is a post hoc analysis of the RITAZAREM clinical trial.
Ellen Romich   +62 more
wiley   +1 more source

Impact of Evolving Treatment Patterns on Interstitial Lung Disease Progression in Systemic Sclerosis Using the European Scleroderma Trials and Research Database

open access: yesArthritis &Rheumatology, EarlyView.
Objective The treatment landscape for systemic sclerosis‐associated interstitial lung disease (SSc‐ILD) has evolved with increasingly available immunosuppressive therapies (ISTs) and antifibrotic treatments. However, their real‐world use remains unclear.
Corrado Campochiaro   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy